Costs of Formal and Informal Home Care and Quality of Life of Patients with Multiple Sclerosis in Sweden

Abstract

A629 ment was associated with 38% fewer unplanned admissions (981 vs. 604, X 1 2 = 89.2, p< 0.001) and 58% fewer unplanned bed nights (8,817 vs. 3,681, X 1 2 = 2109.8, p< 0.001) in the year following treatment initiation compared with the year before. A 14% reduction in all outpatient appointments was also observed, due principally to a 25% reduction in neurological outpatient appointments (from 7,826 to 5,901, X 1 2 = 269.7, p< 0.001). Evidence from this study indicates that duration of treatment is a significant factor in this response; patients receiving between 12 and 14 doses (n= 1,122) experienced 70% reduction in unplanned admissions and 90% reduction in unplanned bed nights. ConClusions: Our data support the notion that natalizumab treatment significantly reduces unplanned hospital treatment and outpatient attendance.

Distress improves after mindfulness training for progressive MS: A pilot randomised trial

“…Previous work indicates issues with all the five domains of the EQ-5D [39]. The absence of questions related to cognition and fatigue which are often major issues in people with progressive MS have also been queried [40,41].…”